TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $86,323,000 | -58.0% | 4,727,415 | -58.1% | 1.98% | -62.9% |
| Q4 2020 | $205,584,000 | +2.0% | 11,295,846 | 0.0% | 5.34% | -15.0% |
| Q3 2020 | $201,518,000 | -2.2% | 11,295,846 | -1.7% | 6.28% | -4.6% |
| Q2 2020 | $205,960,000 | +2.4% | 11,486,905 | -13.3% | 6.58% | -14.2% |
| Q1 2020 | $201,055,000 | -23.1% | 13,244,711 | 0.0% | 7.67% | +36.0% |
| Q4 2019 | $261,318,000 | +14.7% | 13,244,711 | 0.0% | 5.64% | +23.7% |
| Q3 2019 | $227,809,000 | -2.8% | 13,244,711 | 0.0% | 4.56% | +14.5% |
| Q2 2019 | $234,431,000 | -56.6% | 13,244,711 | -50.0% | 3.98% | -30.9% |
| Q1 2019 | $539,590,000 | – | 26,489,422 | – | 5.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |